Acceleration of c-myc-Induced Hepatocarcinogenesis by Co-Expression of Transforming Growth Factor (TGF)-α in Transgenic Mice Is Associated with TGF-β1 Signaling Disruption
- 1 June 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 154 (6) , 1693-1700
- https://doi.org/10.1016/s0002-9440(10)65425-9
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma developmentOncogene, 1998
- TGF-β SIGNAL TRANSDUCTIONAnnual Review of Biochemistry, 1998
- Imprinted M6p/Igf2 receptor is mutated in rat liver tumorsOncogene, 1998
- Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liverOncogene, 1998
- Regulation of Cell Cycle-Related Genes in Rat Hepatocytes by Transforming Growth Factor β1Biochemical and Biophysical Research Communications, 1997
- Interspecies comparison of liver carcinogenesis: implications for cancer risk assessmentCarcinogenesis: Integrative Cancer Research, 1997
- Mice Lacking p27 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary TumorsCell, 1996
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994